Pluristem Announces Appointments of Two Directors to Board

HAIFA, Israel, Jan. 06, 2021 (GLOBE NEWSWIRE) -- PluristemTherapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading regenerative medicine company developing a platform of novel biological therapeutic products, is pleased to announce the appointment of Ms. Maital Shemesh-Rasmussen, a global health-tech marketing strategist, and Mr. Rami Levi, a leader in global marketing and international governmental affairs, to its Board of Directors...
Login to comment.